Europe Drug Discovery Platforms Market Size & Outlook
Related Markets
Europe drug discovery platforms market highlights
- The Europe drug discovery platforms market generated a revenue of USD 916.1 million in 2025.
- The market is expected to grow at a CAGR of 15% from 2026 to 2033.
- In terms of segment, small molecule was the largest revenue generating drug type in 2025.
- Large Molecule is the most lucrative drug type segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 916.1 million |
| Market revenue in 2033 | USD 2,815.3 million |
| Growth rate | 15% (CAGR from 2026 to 2033) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
Other key industry trends
- In terms of revenue, Europe region accounted for 27.0% of the global drug discovery platforms market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,645.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Discovery Platforms Market Scope
Drug Discovery Platforms Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Optibrium | View profile | 51-100 | Cambridge, Cambridgeshire, United Kingdom, Europe | https://optibrium.com/ |
| Relay Therapeutics | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | http://relaytx.com/ |
| Insitro | View profile | 101-250 | South San Francisco, California, United States, North America | http://www.insitro.com |
| Atomwise | View profile | 51-100 | San Francisco, California, United States, North America | http://www.atomwise.com |
| Recursion Pharmaceuticals Inc Class A | View profile | 500 | 41 S Rio Grande Street, Salt Lake City,, UT, United States, 84101 | https://www.recursion.com |
| Insilico Medicine | View profile | 101-250 | Hong Kong, Hong Kong Island, Hong Kong, Asia | http://www.insilico.com |
| Genedata AG | View profile | 51-100 | Basel, Basel-Stadt, Switzerland, Europe | https://www.genedata.com/ |
| Schrodinger Inc Ordinary Shares | View profile | 787 | 1540 Broadway, 24th Floor, New York, NY, United States, 10036 | https://www.schrodinger.com |
| Dassault Systemes SE | View profile | 23811 | 10, Rue Marcel Dassault, Velizy-Villacoublay, France, 78140 | https://www.3ds.com |
| Certara Inc Ordinary Shares | View profile | 1391 | 100 Overlook Center, Suite 101, Princeton, NJ, United States, 08540 | https://www.certara.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Europe drug discovery platforms market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery platforms market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 83.05% in 2025. Horizon Databook has segmented the Europe drug discovery platforms market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Europe drug discovery platforms market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe drug discovery platforms market databook
-
Our clientele includes a mix of drug discovery platforms market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe drug discovery platforms market , including forecasts for subscribers. This continent databook contains high-level insights into Europe drug discovery platforms market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Europe drug discovery platforms market size, by country, 2021-2033 (US$M)
Europe Drug Discovery Platforms Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
